Go to:
Logótipo
Você está em: Start > Publications > View > Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas
Map of Premises
Principal
Publication

Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas

Title
Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas
Type
Article in International Scientific Journal
Year
2006
Authors
Botelho, CHA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Magalhaes, AVD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Mello, PA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernando Schmitt
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Casulari, LA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 64
Pages: 60-66
ISSN: 0004-282X
Other information
Authenticus ID: P-004-MVC
Abstract (EN): The subcellular events implicated on the formation and behavior of pituitary adenomas are not fully understood. In this study we investigated the presence of p53, Ki-67 and c-erb B2 in 38 pituitary adenomas with immunohistochemical positivity for GH and prolactin (n=26; 68.4%), for prolactin (n=9; 23.7%) and for GH (n=3. 7.8%). The analyses revealed the following results: 24 (63.2%) tumors expressed variable positivity for c-erb B2, 11 (28.9%) expressed p53 positivity and 11 (28.9%) tumors were variably positive for Ki-67. Our results demonstrated a high percentage of GH/prolactin-, prolactin- and GH-secreting tumors with immunohistochemical positivity for c-erb B2. Once this membrane receptor is related to growth factors EGF and TGF alpha and both have a definite effect on tumor growth, our data suggest a possible role for c-erb B2 on the evolution of these tumors.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

CEREBROSPINAL-FLUID CYTOMORPHOLOGIC FINDINGS IN 41 INTRACRANIAL TUMORS - A RETROSPECTIVE REVIEW (1995)
Another Publication in an International Scientific Journal
SA, MJ; VAZ, R; CRUZ, C
Autoimmune atrophic gastritis presenting as myelopathy in a young patient [Mielopatia como apresentação de gastrite atrófica autoimune em um doente jovem] (2012)
Another Publication in an International Scientific Journal
Postal, ATC; Franca, S; Costa, D; Joana Guimaraes
Non-functioning pituitary adenomas: Clinical features and immunohistochemistry [Caracterização clínica e imunoistoquímica dos adenomas clinicamente não-funcionantes de hipófise] (2005)
Article in International Scientific Journal
Alves Ferreira, JE; De Mello, PA; De Magalhaes, AV; Aguiar Botelho, CH; Naves, LA; Nose, V; Fernando Schmitt
Non-functioning pituitary adenomas: clinical features and immunohistochemistry (2005)
Article in International Scientific Journal
Ferreira, JEA; de Mello, PA; de Magalhaes, AV; Botelho, CHA; Naves, LA; Nose, V; Fernando Schmitt
Invasive medullary thymoma associated with myasthenia gravis: An unusual case (2000)
Article in International Scientific Journal
Reis Filho, JS; Milanezi, MF; Moreira, CG; Werneck, LC; Boscardin, P; Ioshii, SO; Fernando Schmitt

See all (15)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-21 at 21:18:37 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book